A secondary analysis on results of the CAPTION trial pointed to a role for pharmacists in helping tailor the treatment regimen for patients with hypertension, although it did not improve blood pressure control.
The CAPTION trial, conducted at the University of Iowa, evaluated the influence of a pharmacist-physician collaboration in managing hypertension in 625 patients with uncontrolled hypertension. Using JNC7 guidelines, pharmacists worked with physicians to recommend changes and also participated in educating patients on self-management. While the study found that pharmacists initiated 4.9 changes in dose or drug compared with 1.1 on average in usual care, during the 9 month period when the study was conducted across 32 care centers, there was no significant difference between the total nuber of medications between groups. According to one of the study authors, pharmacists were tried to tailor—not intensify—the regimen to meet the goals.
The study was presented at the recently concluded 2015 annual meeting of the American Society of Hypertension.
Complete report on MedPage Today: http://bit.ly/1FvD1T9
Patients With HFrEF, HFpEF See Different Functional Capacity Benefits With Dapagliflozin
December 7th 2023The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as well as 6-minute walk distance.
Read More
Black Patients With Ulcerative Colitis Less Likely to Undergo IPAA Than White Patients
December 7th 2023Overall, the number of patients discharged from hospitals with an ulcerative colitis diagnosis increased between 2009 and 2018, but the number of patients opting for ileal pouch–anal anastomosis (IPAA) decreased.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.
Read More
New Investigation Analyzes Magnetic Resonance Measures of DMD for Disease Progression
December 7th 2023Investigators evaluated longitudinal MRI and spectroscopy outcomes and ambulatory function among 180 patients with Duchenne muscular dystrophy (DMD) to establish the utility and reproducibility of magnetic resonance measures of muscle quality at different disease stages.
Read More